Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,268

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,852

Class I recallsReasonable probability of serious health consequences

24,397

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,085 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/family-farmstead-dairy-announces-recall-raw-mild-cheddar-cheese-due-potential-e-coli-o157h7Published October 15, 2026

Most affected stateHawaii 200 recalls mention this state

State: MN ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 16, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

FDA Recall Ongoing2026 recordClass II

Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93.

by MYLAN PHARMACEUTICALS INC

Reason: Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

2% Chlorhexidine Gluconate* Cloth, Non-sterile, 6 Disposable cloths, Sage Products LLC, 3909 Three Oaks Road, Cary, Illinois 60013. NDC: 53462-705-26

by Sage Products, LLC

Reason: Cross Contamination with Other Products
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01

by Teva Pharmaceuticals USA, Inc

Reason: Presence of Foreign Tablets/Capsules
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass III

Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30.

by Supernus Pharmaceuticals, Inc.

Reason: Failed dissolution specifications.
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-81. Vial Label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, Single Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-00.

by MYLAN PHARMACEUTICALS INC

Reason: Failed Dissolution Specifications
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 90ml - 3 fl. oz. Tube, Made in the U.S.A, Distributed by Allies Group Pte Ltd, Singapore 068914. UPC 8 885014 075853

by Allies Group Inc.

Reason: Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 20ml - 0.7 fl. oz. Tube, Made in the U.S.A, Distributed by Allies Group Pte Ltd, Singapore 068914. UPC 8 885014 074733

by Allies Group Inc.

Reason: Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 3ml - 0.1 fl. oz, Sachet: Single use only, Made in the U.S.A, Distributed by Allies Group Pte Ltd, Singapore 068914.UPC 8 885014 073293

by Allies Group Inc.

Reason: Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 50ML - 1.7 fl. oz Tube, Made in U.S.A, Distributed by Allies Group Pte Ltd, Singapore 068914. UPC 8 885014 073224

by Allies Group Inc.

Reason: Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass III

Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA, Distributed by: Bionpharma Inc., Princeton, NJ 08540 NDC 69452-206-20.

by Bionpharma Inc.

Reason: Presence of Foreign Tablets/Capsules
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3583-01.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-9647-12.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-995-24.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-4114-50.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-9549-50.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3814-50.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Container, sterile, Nonpyrogenic, iso-osmotic solution in Dextrose, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in the USA, NDC 43066-360-20.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAXY Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, NDC 0338-9648-12.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

Data last updated: October 16, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.